Clinical trial
Reversal of Lipid-Induced Insulin Resistance
NCT02193295 is registered in ClinicalTrials.gov with Yale University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Reversal of Lipid-Induced Insulin Resistance
- Lead sponsor
- Yale University
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- October 31, 2002
- Completion date
- December 31, 2034
- Enrollment
- 250 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
insulin resistance, nafld